0 items USD 0.00Search
Your search for "current partnering global muscular dystrophy partnering 2010 2016" gave back 222635 results.
Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H2 2020 Summary According to the recently published report 'Nuclear Factor...
Catalog:
Global Markets Direct
August 2020
Price: USD 3,500.00
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H1 2018 Summary...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018 Summary Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4)...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Exportin 1 - Pipeline Review, H1 2020 Summary According to the recently published report 'Exportin 1 - Pipeline Review, H1 2020'; Exportin...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) - Pipeline Review, H1 2019 Summary Global Markets Direct...
Catalog:
Global Markets Direct
January 2019
Price: USD 2,000.00
The global Duchenne Muscular Dystrophy market size was valued at US$ 1176.8 million in 2023. With growing demand in downstream market, the Duchenne...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Exportin 1 - Drugs In Development, 2021 Summary Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Muscle Atrophy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle...
Catalog:
Global Markets Direct
September 2018
Price: USD 2,000.00
Muscle Atrophy - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle...
Catalog:
Global Markets Direct
March 2018
Price: USD 2,000.00
Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic muscle disorder with onset during adulthood most often between 40 and 60 years of age...
Catalog:
LPI
February 2023
Price: USD 3,660.00
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Duchenne muscular dystrophy, sometimes shortened to DMD or just Duchenne, is a rare genetic disease. It predominantly affects males, but, in rare...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic muscle disorder with onset during adulthood most often between 40 and 60 years of age...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Highlights The global Becker Muscular Dystrophy Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
